Publications by authors named "Hugues Barletta"

Claim this Profile
R
Real-World Experience of Bevacizumab as First-Line Treatment for Ovarian Cancer: The GINECO ENCOURAGE Cohort of 468 French Patients.
Dominique Berton, Anne Floquet, Willy Lescaut, Gabriel Baron, Marie-Christine Kaminsky, Hugues Barletta

Front Pharmacol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution in the real-world therapeutic strategies in more than 20,000 women with breast cancer having received human epidermal growth factor receptor 2-targeted treatments: Results from the french personalized reimbursement model database (2011-2018).
Paul Cottu, Bruno Coudert, David Perol, Anne Doly, Julien Manson, Hugues Barletta

Eur J Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of multidisciplinary tumour board in the management of ovarian carcinoma in the first-line setting. Exhaustive analysis from the Rhone-Alpes region.
Domenico Ferraioli, Olivia Bally, Pierre Meeus, David Benayoun, Naoual Bakrin, Hugues Barletta

Eur J Cancer Care (Engl)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Impact of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in France.
Gregory Katz, Olivier Romano, Cyril Foa, Anne-Lise Vataire, Jean-Victor Chantelard, Hugues Barletta

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Adjuvant therapy for breast cancer patients: treatment decision tree from a French cancer network].
Thomas Bachelot, Isabelle Ray-Coquard, David Coeffic, Hugues Barletta, Marie-Claude Gouttebel

Bull Cancer· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis